Eisai China Inc. Signs License Agreement in China for -Lipon 300 STADA for Diabetic Neuropathic Pain
[ 2008/07/30 | Eisai Co., Ltd. | Pharmaceuticals | Tokyo | TSE1(PRIME) ]

The Company's Official Page
http://www.eisai.co.jp/enews/enews200846.html
Back To Previous Page
Dear User,
JPubb program could not collect the texts of this press-release from the official page, which perhaps mainly comprises tables, charts or images. Please refer to the official page indicated above. -- by JPubb

Latest News: Pharmaceuticals

    この内容でのリリース掲載はまだ無いか、集計されておりません。

more
    この内容でのリリース掲載はまだ無いか、集計されておりません。

more

Most Popular: Pharmaceuticals

1. Proton Pump Inhibitor ACIPHEX 20 mg Rece...
Eisai Co., Ltd. 2008/07/01
2. KAKEN PHARMACEUTICAL CO. and ELITRA PHAR...
Kaken Pharmaceutical Co.,Ltd. 2003/02/20
3. Eisai China Inc. Signs License Agreement...
Eisai Co., Ltd. 2008/07/30
4. Taisho Reaches Agreement on the Developm...
Taisho Pharmaceutical Holdings Co., Ltd. 2009/01/13
5. Announcement of FY2009 1st Quarter Finan...
Mitsubishi Tanabe Pharma Corporation 2009/07/30

Latest News: Eisai Co., Ltd.


more

Most Popular: Eisai Co., Ltd.

1. FDA Accepts for Review Eisai's NDA ...
2009/11/25

Categories

Go to Page Top

View: Smartphone | PC

Language: English | Japanese

■Home

■Terms & Conditions

■Twitter ■Facebook

■About Us